Kim JH - Search Results

1

A prospective phase II trial of S-1 and cisplatin-based chemoradiotherapy for locoregionally advanced esophageal cancer.

Chang H, Shin SK, Cho BC, Lee CG, Kim CB, Kim DJ, Lee JG, Hur J, Lee CY, Bae MK, Kim HR, Lee SK, Park JC, Lee H, Kim HI, Chung H, Cha J, Lee YC, Kim JH. Chang H, et al. Among authors: kim cb, kim hi, kim dj, kim hr, kim jh. Cancer Chemother Pharmacol. 2014 Apr;73(4):665-71. doi: 10.1007/s00280-013-2371-y. Epub 2014 Feb 22. Cancer Chemother Pharmacol. 2014. PMID: 24562525 Clinical Trial.

2

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.

Heo SJ, Jung I, Lee CK, Kim JH, Lim SM, Moon YW, Shim HS, Jeong J, Kim JH, Kim HR, Cho BC. Heo SJ, et al. Among authors: kim hr, kim jh. Cancer Chemother Pharmacol. 2016 Mar;77(3):539-48. doi: 10.1007/s00280-016-2968-z. Epub 2016 Jan 25. Cancer Chemother Pharmacol. 2016. PMID: 26811178 Clinical Trial.

3

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer.

Lee YJ, Lee CG, Cho BC, Kim GE, Choi HJ, Choi EC, Sohn JH, Kim JH. Lee YJ, et al. Among authors: kim ge, kim jh. Head Neck. 2010 Feb;32(2):235-43. doi: 10.1002/hed.21177. Head Neck. 2010. PMID: 19572288 Clinical Trial.

4

Paclitaxel combined with ifosfamide in anthracycline- and docetaxel-pretreated metastatic breast cancer: activity independence of prior docetaxel resistance.

Moon YW, Sohn JH, Choi HJ, Chang H, Park BW, Kim SI, Park S, Koo JS, Kim YT, Roh JK, Chung HC, Kim JH. Moon YW, et al. Among authors: kim si, kim yt, kim jh. Cancer Chemother Pharmacol. 2010 Aug;66(3):425-31. doi: 10.1007/s00280-009-1176-5. Epub 2009 Dec 15. Cancer Chemother Pharmacol. 2010. PMID: 20012956

5

Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer.

Lee YJ, Choi HJ, Kim SK, Chang J, Moon JW, Park IK, Kim JH, Cho BC. Lee YJ, et al. Among authors: kim sk, kim jh. Cancer. 2010 Mar 1;116(5):1336-43. doi: 10.1002/cncr.24877. Cancer. 2010. PMID: 20066717 Free article.

6

Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer except both exon 19 deletion and exon 21 L858R: a retrospective analysis in Korea.

Baek JH, Sun JM, Min YJ, Cho EK, Cho BC, Kim JH, Ahn MJ, Park K. Baek JH, et al. Among authors: kim jh. Lung Cancer. 2015 Feb;87(2):148-54. doi: 10.1016/j.lungcan.2014.11.013. Epub 2014 Nov 29. Lung Cancer. 2015. PMID: 25498243

7

An open label, multicenter, phase II study of dovitinib in advanced thyroid cancer.

Lim SM, Chung WY, Nam KH, Kang SW, Lim JY, Kim HG, Shin SH, Sun JM, Kim SG, Kim JH, Kang CW, Kim HR, Cho BC. Lim SM, et al. Among authors: kim hg, kim sg, kim hr, kim jh. Eur J Cancer. 2015 Aug;51(12):1588-95. doi: 10.1016/j.ejca.2015.05.020. Epub 2015 Jun 9. Eur J Cancer. 2015. PMID: 26070683 Clinical Trial.

8

Tumor MET expression profile predicts the outcome of non-small cell lung cancer patients receiving epidermal growth factor receptor tyrosine kinase inhibitors.

Chang H, Zhang X, Cho BC, Park HJ, Kim JH. Chang H, et al. Among authors: kim jh. Thorac Cancer. 2014 Nov;5(6):517-24. doi: 10.1111/1759-7714.12122. Epub 2014 Oct 23. Thorac Cancer. 2014. PMID: 26767046 Free PMC article.

9

A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806).

Lim SM, Cho BC, Kim SW, Kang SY, Heo DS, Kim HT, Lee DH, Kim DW, Jung M, Choi JH, Shim HS, Choi JR, Kim JH. Lim SM, et al. Among authors: kim dw, kim sw, kim ht, kim jh. Lung Cancer. 2016 Mar;93:1-8. doi: 10.1016/j.lungcan.2015.12.005. Epub 2015 Dec 29. Lung Cancer. 2016. PMID: 26898607 Clinical Trial.

10

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).

Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC. Kim HR, et al. Among authors: kim dw, kim sw, kim jh. Oncotarget. 2017 Feb 28;8(9):15943-15951. doi: 10.18632/oncotarget.13056. Oncotarget. 2017. PMID: 27823977 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31,284 results

Search Page